Legal & General Group
STRO icon

Legal & General Group’s Sutro Biopharma STRO Stock Holding History

Legal & General Group’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-707
Closed -$4.6K – 3535
2025
Q1 		$4.6K Hold
707
– – ﹤0.01% 3288
2024
Q4 		$13K Hold
707
– – ﹤0.01% 3186
2024
Q3 		$24.5K Hold
707
– – ﹤0.01% 2968
2024
Q2 		$20.7K Buy
707
+211
+43% +$8.34K ﹤0.01% 3002
2024
Q1 		$28K Hold
496
– – ﹤0.01% 2866
2023
Q4 		$21.3K Hold
496
– – ﹤0.01% 3007
2023
Q3 		$17.2K Sell
496
-83
-14% -$3.62K ﹤0.01% 3096
2023
Q2 		$26.9K Buy
579
+64
+12% +$3.19K ﹤0.01% 2984
2023
Q1 		$23.8K Hold
515
– – ﹤0.01% 3018
2022
Q4 		$41.6K Buy
515
+55
+12% +$3.82K ﹤0.01% 2976
2022
Q3 		$26K Buy
460
+89
+24% +$5.27K ﹤0.01% 3139
2022
Q2 		$19K Sell
371
-756
-67% -$42.2K ﹤0.01% 3260
2022
Q1 		$92K Hold
1,127
– – ﹤0.01% 2889
2021
Q4 		$167K Hold
1,127
– – ﹤0.01% 2783
2021
Q3 		$213K Buy
1,127
+635
+129% +$121K ﹤0.01% 2673
2021
Q2 		$92K Buy
492
+151
+44% +$29.6K ﹤0.01% 2771
2021
Q1 		$78K Buy
341
+27
+9% +$6.41K ﹤0.01% 2688
2020
Q4 		$68K Buy
314
+20
+7% +$3.31K ﹤0.01% 2711
2020
Q3 		$30K Buy
294
+29
+11% +$2.74K ﹤0.01% 2852
2020
Q2 		$21K Buy
265
+125
+89% +$12K ﹤0.01% 3055
2020
Q1 		$14K Sell
140
-50
-26% -$5.25K ﹤0.01% 3055
2019
Q4 		$21K Buy
190
+8
+4% +$825 ﹤0.01% 3171
2019
Q3 		$17K Hold
182
– – ﹤0.01% 3186
2019
Q2 		$21K Buy
182
+83
+84% +$9.15K ﹤0.01% 3179
2019
Q1 		$11K Hold
99
– – ﹤0.01% 3238
2018
Q4 		$9K Buy
+99
New +$11.9K ﹤0.01% 3280

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Legal & General Group's STRO Position: Q2 2025 in Review

Legal & General Group sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 707 shares — an estimated $4.6K sold.

Legal & General Group first reported a position in STRO in Q4 2018 and held it in 26 quarters. The position peaked at $213K in Q3 2021. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • Legal & General Group reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 707 Sutro Biopharma shares in Q2 2025, an estimated $4.6K.
  • Legal & General Group first reported a position in Sutro Biopharma in Q4 2018 and held it in 26 quarters.
  • Legal & General Group's Sutro Biopharma position peaked at $213K in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.